CD40 and neoplasm: Additionally, the concurrent administration of TNF and anti-CD40 mAb boosts neutrophil activation and toxicity, further promoting tumor cell apoptosis and clearance by enhancing oxidative damage and N1 neutrophil recruitment in the TME (13, 101).